Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90. doi:10.2337/dc13-1041
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16:349–362. doi:10.1038/s41574-020-0355-7
   PubMed Web of Science ®Google Scholar
• Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068–1083. doi:10.1016/S0140-6736(13)62154-6
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Katsiki N, Behnam B, et al. MicroRNAs and type 2 diabetes mellitus: molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism. 2018;87:48–55. doi:10.1016/j.metabol.2018.07.001
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Farrokhi FR, Butler AE, et al. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234:8152–8161. doi:10.1002/jcp.27603
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Butler AE, Barreto GE, et al. Antioxidative potential of antidiabetic agents: a possible protective mechanism against vascular complications in diabetic patients. J Cell Physiol. 2019;234:2436–2446. doi:10.1002/jcp.27278
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Mohammadi MT, Sahebkar A. Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats. Biomed Pharmacother. 2018;98:333–337. doi:10.1016/j.biopha.2017.12.077
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Mohammadi MT, Sahebkar A. PPAR-α Agonist improves hyperglycemia-induced oxidative stress in pancreatic cells by potentiating antioxidant defense system. Drug Res. 2018;68:355–360. doi:10.1055/s-0043-121143
   Web of Science ®Google Scholar
• Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017;40:257–262. doi:10.1016/j.bj.2017.06.007
   PubMed Web of Science ®Google Scholar
• Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766
   PubMed Web of Science ®Google Scholar
• Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171(2):179–189. doi:10.1007/s10517-021-05191-7
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Lhaf F, Sathyapalan T, et al. Effects of novel antidiabetes agents on apoptotic processes in diabetes and malignancy: implications for lowering tissue damage. Life Sci. 2019;231:116538. doi:10.1016/j.lfs.2019.06.013
   PubMed Web of Science ®Google Scholar
• Dinić S, Arambašić Jovanović J, Uskoković A, et al. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front Endocrinol. 2022;13:1006376. doi:10.3389/fendo.2022.1006376
   PubMed Web of Science ®Google Scholar
• Nakamura K, Miyoshi T, Yoshida M, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23:3587. doi:10.3390/ijms23073587
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124:1160–1162. doi:10.1161/CIRCRESAHA.118.314665
   PubMed Web of Science ®Google Scholar
• Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407–1418. doi:10.1056/NEJMoa1608664
   PubMed Web of Science ®Google Scholar
• Zhang ZD, Tao Q, Qin Z, et al. Uptake and transport of naringenin and its antioxidant effects in human intestinal epithelial Caco-2 cells. Front Nutr. 2022;9:894117. doi:10.3389/fnut.2022.894117
   PubMed Web of Science ®Google Scholar
• Calis Z, Dasdelen D, Baltaci AK, et al. Naringenin prevents inflammation, apoptosis, and DNA damage in potassium oxonate-induced hyperuricemia in rat liver tissue: roles of Cytochrome C, NF-κB, Caspase-3, and 8-hydroxydeoxyguanosine. Metab Syndr Relat Disord. 2022;20:473–479. doi:10.1089/met.2022.0028
   PubMed Web of Science ®Google Scholar
• Du Y, Ma J, Fan Y, et al. Naringenin: a promising therapeutic agent against organ fibrosis. Oxid Med Cell Longev. 2021;2021:1210675. doi:10.1155/2021/1210675
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Cao Z, et al. Naringenin ameliorates homocysteine induced endothelial damage via the AMPKα/Sirt1 pathway. J Adv Res. 2021;34:137–147. doi:10.1016/j.jare.2021.01.009
   PubMed Web of Science ®Google Scholar
• Dayarathne LA, Ranaweera SS, Natraj P, et al. The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells. J Vet Sci. 2021;22:e92. doi:10.4142/jvs.2021.22.e92
   PubMed Web of Science ®Google Scholar
• Yang Y, Trevethan M, Wang S, et al. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: an update on bioavailability, pharmacokinetics, and mechanisms. J Nutr Biochem. 2022;104:108967. doi:10.1016/j.jnutbio.2022.108967
   PubMed Web of Science ®Google Scholar
• Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Card. 1972;30:595–602. doi:10.1016/0002-9149(72)90595-4
   PubMed Web of Science ®Google Scholar
• Ritchie, R.H.; Abel, E.D, eds. Basic mechanisms of diabetic heart disease. Circ Res. 2020, 126, 1501-1525, doi:10.1161/CIRCRESAHA.120.315913
   PubMed Web of Science ®Google Scholar
• Nakamura M, Sadoshima J. Cardiomyopathy in obesity, insulin resistance and diabetes. J Physiol. 2020;598:2977–2993. doi:10.1113/JP276747
   PubMed Web of Science ®Google Scholar
• Mátyás C, Kovács A, Németh BT, et al. Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models. Cardiovasc Diabetol. 2018;17:13. doi:10.1186/s12933-017-0645-0
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhang Z, Zheng C, et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat. Rev. Cardiol. 2020;17:585–607. doi:10.1038/s41569-020-0339-2
   PubMed Web of Science ®Google Scholar
• Jia G, Whaley Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21–28. doi:10.1007/s00125-017-4390-4
   PubMed Web of Science ®Google Scholar
• Sadasivam N, Kim YJ, Radhakrishnan K, et al. Oxidative stress, genomic integrity, and liver diseases. Molecules. 2022;27:3159. doi:10.3390/molecules27103159
   PubMed Web of Science ®Google Scholar
• Limbu S, Prosser BL, Lederer WJ, et al. X-ROS signaling depends on length-dependent calcium buffering by troponin. Cells. 2021 May 13;10(5):1189. doi:10.3390/cells10051189
   PubMed Web of Science ®Google Scholar
• Ganjikunta VS, Maddula RR, Bhasha S, et al. Cardioprotective effects of 6-gingerol against alcohol-induced ROS-mediated tissue injury and apoptosis in rats. Molecules. 2022 Dec 6;27(23):8606. doi:10.3390/molecules27238606
   PubMed Web of Science ®Google Scholar
• Shen S, He F, Cheng C, et al. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway. Biomed Pharmacother. 2021 Jan;133:110990. doi:10.1016/j.biopha.2020.110990
   PubMed Web of Science ®Google Scholar
• Şirin G, Borlu F. Is cardiac troponin I valuable to detect low-level myocardial damage in congestive heart failure? Sisli Etfal Hastan Tip Bul. 2019 Jul 10;53(2):172–178. doi:10.14744/SEMB.2018.45336
   PubMed Web of Science ®Google Scholar
• Luc K, Schramm-Luc A, Guzik TJ, et al. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019 Dec;70(6). doi:10.26402/jpp.2019.6.01
   PubMed Web of Science ®Google Scholar
• Dey S, DeMazumder D, Sidor A, et al. Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure. Circ Res. 2018;123:356–371. doi:10.1161/CIRCRESAHA.118.312708
   PubMed Web of Science ®Google Scholar
• Hegyi B, Pölönen RP, Hellgren KT, et al. Cardiomyocyte Na+ and Ca2 + mishandling drives vicious cycle involving CaMKII, ROS, and ryanodine receptors. Basic Res Cardiol. 2021;116:58. doi:10.1007/s00395-021-00900-9
   PubMed Web of Science ®Google Scholar
• Coudriet GM, Delmastro Greenwood MM, Previte DM, et al. Treatment with a catalytic superoxide dismutase (SOD) mimetic improves liver steatosis, insulin sensitivity, and inflammation in obesity-induced type 2 diabetes. Antioxidants. 2017;6:85. doi:10.3390/antiox6040085
   Web of Science ®Google Scholar
• Sultan A, Singh J, Howarth FC. Mechanisms underlying electro-mechanical dysfunction in the Zucker diabetic fatty rat heart: a model of obesity and type 2 diabetes. Heart Fail Rev. 2020;25:873–886. doi:10.1007/s10741-019-09872-4
   PubMed Web of Science ®Google Scholar
• Lekli I, Haines DD, Balla G, et al. Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion-associated cardiac arrhythmias. J Cell Mol Med. 2017;21:1058–1072. doi:10.1111/jcmm.13053
   PubMed Web of Science ®Google Scholar
• Liang Y, Li J, Lin Q, et al. Research progress on signaling pathway-associated oxidative stress in endothelial cells. Oxid Med Cell Longev. 2017;2017:7156941.. doi:10.1155/2017/7156941
   PubMed Web of Science ®Google Scholar
• Cui Y, Song M, Xiao B, et al. ROS-mediated mitophagy and apoptosis are involved in aluminum-induced femoral impairment in mice. Chem Biol Interact. 2021;349:109663. doi:10.1016/j.cbi.2021.109663
   PubMed Web of Science ®Google Scholar
• Hung SY, Chen WF, Lee YC, et al. Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer. Phytomedicine. 2021;92:153720. doi:10.1016/j.phymed.2021.153720
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang H, Li D, et al. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway. J Cell Mol Med. 2021;25(17):8159–8168. doi:10.1111/jcmm.16574
   PubMed Web of Science ®Google Scholar
• Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84–93. doi:10.1016/j.yjmcc.2015.12.011
   PubMed Web of Science ®Google Scholar
• Black HS. A synopsis of the associations of oxidative stress, ROS, and antioxidants with diabetes mellitus. Antioxidants (Basel). 2022;11(10):2003. doi:10.3390/antiox11102003
   PubMedGoogle Scholar
• Chen M, Li L, Wang Z, et al. High molecular weight hyaluronic acid regulates P. gingivalis–induced inflammation and migration in human gingival fibroblasts via MAPK and NF-κB signaling pathway. Arch Oral Biol. 2019;98:75–80. doi:10.1016/j.archoralbio.2018.10.027
   PubMed Web of Science ®Google Scholar
• Chen X, Qian J, Wang L, et al. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress. Endocrine. 2018;60:83–94. doi:10.1007/s12020-018-1525-4
   PubMed Web of Science ®Google Scholar
• Luo J, Yan D, Li S, et al. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. J Cell Mol Med. 2020;24:1760–1773. doi:10.1111/jcmm.14870
   PubMed Web of Science ®Google Scholar
• Li K, Zhai M, Jiang L, et al. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway. Oxid Med Cell Longev. 2019;2019:6746907. doi:10.1155/2019/6746907
   PubMed Web of Science ®Google Scholar
• Jin Q, Zhu Q, Wang K, et al. Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF-κB signalling pathway in diabetic cardiomyopathy rats. Mol Med Rep. 2021;23:215. doi:10.3892/mmr.2021.11854
   PubMed Web of Science ®Google Scholar
• Ulasov AV, Rosenkranz AA, Georgiev GP, et al. Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci. 2022;291:120111. doi:10.1016/j.lfs.2021.120111
   PubMed Web of Science ®Google Scholar
• Zhang Q, Liu J, Duan H, et al. Activation of Nrf2/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021;34:43–63. doi:10.1016/j.jare.2021.06.023
   PubMed Web of Science ®Google Scholar
• Shi YL, Zhang YP, Luo H, et al. Trilobatin, a natural food additive, exerts anti-type 2 diabetes effect mediated by Nrf2/ARE and IRS-1/GLUT2 signaling pathways. Front Pharmacol. 2022;13:62. doi:10.3389/fphar.2022.828473
   Web of Science ®Google Scholar
• Li D, Liu X, Pi W, et al. Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1/Nrf2 signaling pathway activation. Front Pharmacol. 2022;12:4175. doi:10.3389/fphar.2021.808480
   Web of Science ®Google Scholar
• Wu X, Zhou X, Lai S, et al. Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo. FASEB J. 2022;36:e22505. doi:10.1096/fj.202200543RRR
   PubMed Web of Science ®Google Scholar
• Fang Q, Liu X, Ding J, et al. Soluble epoxide hydrolase inhibition protected against diabetic cardiomyopathy through inducing autophagy and reducing apoptosis relying on Nrf2 upregulation and transcription activation. Oxid Med Cell Longev. 2022;2022:3773415. doi:10.1155/2022/3773415
   PubMed Web of Science ®Google Scholar
• Uddandrao VVS, Parim B, Singaravel S, et al. Polyherbal formulation ameliorates diabetic cardiomyopathy through attenuation of cardiac inflammation and oxidative stress Via NF-κB/Nrf-2/HO-1 pathway in diabetic rats. J Cardiovasc Pharmacol. 2022;79:e75–e86. doi:10.1097/FJC.0000000000001167
   PubMed Web of Science ®Google Scholar
• Gu J, Cheng Y, Wu H, et al. Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy. Diabetes. 2017;66:529–542. doi:10.2337/db15-1274
   PubMed Web of Science ®Google Scholar
• Wu S, Zhu J, Wu G, et al. 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway. Oxid Med Cell Longev. 2022: 3027514. doi:10.1155/2022/3027514
   PubMed Web of Science ®Google Scholar
• Dong H, Zhang Y, Huang Y, et al. Pathophysiology of RAGE in inflammatory diseases. Front Immunol. 2022;13:931473. doi:10.3389/fimmu.2022.931473
   PubMedGoogle Scholar
• Guerin Dubourg A, Cournot M, Planesse C, et al. Association between fluorescent advanced glycation End-products and vascular complications in type 2 diabetic patients. Biomed Res Int. 2017;2017:7989180. doi:10.1155/2017/7989180
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wu F, Yang Q, et al. Resveratrol inhibits high glucose-induced H9c2 cardiomyocyte hypertrophy and damage via RAGE-dependent inhibition of the NF-κB and TGF-β1/Smad3 pathways. Evid Based Complement Altern Med. 2022;2022:7781910. doi:10.1155/2022/7781910
   PubMed Web of Science ®Google Scholar
• Wasim R, Mahmood T, Siddiqui MH, et al. Aftermath of AGE-RAGE cascade in the pathophysiology of cardiovascular ailments. Life Sci. 2022;307:120860. doi:10.1016/j.lfs.2022.120860
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang J, Wang M, et al. Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKCβ signaling pathway: insight from diabetic cardiomyopathy. Anatol J Cardiol. 2020;23:141–150. doi:10.14744/AnatolJCardiol.2019.21504
   PubMed Web of Science ®Google Scholar
• Inacio MD, Costa MC, Lima TFO, et al. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels. Life Sci. 2020;258:118196. doi:10.1016/j.lfs.2020.118196
   PubMed Web of Science ®Google Scholar
• Liang B, Zhou Z, Yang Z, et al. AGEs–RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure. Exp Physiol. 2022;107:879–891. doi:10.1113/EP090042
   PubMed Web of Science ®Google Scholar
• Hegab Z, Mohamed TMA, Stafford N, et al. Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide. FEBS Open Bio. 2017;7:1672–1685. doi:10.1002/2211-5463.12284
   PubMed Web of Science ®Google Scholar
• Arshi B, Chen J, Ikram MA, et al. Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study. Diabetologia. 2023;66:472–481. doi:10.1007/s00125-022-05821-3
   PubMed Web of Science ®Google Scholar
• Willemsen S, Hartog JWL, van Veldhuisen DJ, et al. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction. Am Heart J. 2012;164:742–749e743. doi:10.1016/j.ahj.2012.07.027
   PubMed Web of Science ®Google Scholar
• Hartog JWL, Willemsen S, van Veldhuisen DJ, et al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011;13:899–908. doi:10.1093/eurjhf/hfr067
   PubMed Web of Science ®Google Scholar
• Vermot A, Petit Härtlein I, Smith SME, et al. NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants. 2021;10:890. doi:10.3390/antiox10060890
   Web of Science ®Google Scholar
• Eid SA, Savelieff MG, Eid AA, et al. Nox, Nox, are you there? The role of NADPH oxidases in the peripheral nervous system. Antioxid Redox Signal. 2022;37:613–630. doi:10.1089/ars.2021.0135
   PubMed Web of Science ®Google Scholar
• Elumalai S, Karunakaran U, Lee IK, et al. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells. Redox Biol. 2017;11:126–134. doi:10.1016/j.redox.2016.11.009
   PubMed Web of Science ®Google Scholar
• Gabriela Nunes M-L, Aparecida Vilas Boas E, Carlein C, et al. Evidence for NADPH oxidase activation by GPR40 in pancreatic β-cells. Redox Rep. 2020;25:41–50. doi:10.1080/13510002.2020.1757877
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhu S, Wang X, et al. ShengMai-San attenuates cardiac remodeling in diabetic rats by inhibiting NOX-mediated oxidative stress. Diabetes Metab Syndr Obes. 2021;14:647–657. doi:10.2147/DMSO.S287582
   PubMed Web of Science ®Google Scholar
• Zheng D, Dong S, Li T, et al. Exogenous hydrogen sulfide attenuates cardiac fibrosis through reactive oxygen species signal pathways in experimental diabetes mellitus models. Cell Physiol Biochem. 2015;36:917–929. doi:10.1159/000430266
   PubMedGoogle Scholar
• Capece D, Verzella D, Flati I, et al. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43:757–775. doi:10.1016/j.it.2022.07.004
   PubMed Web of Science ®Google Scholar
• Li L, Luo W, Qian Y, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. 2019;59:152774. doi:10.1016/j.phymed.2018.11.034
   PubMed Web of Science ®Google Scholar
• Liu X, Guo B, Zhang W, et al. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. J. Biochem. 2021;170:349–362. doi:10.1093/jb/mvab047
   PubMed Web of Science ®Google Scholar
• Belali OM, Ahmed MM, Mohany M, et al. LCZ696 protects against diabetic cardiomyopathy-induced myocardial inflammation, ER stress, and apoptosis through inhibiting AGEs/NF-κB and PERK/CHOP signaling pathways. Int J Mol Sci. 2022;23:1288. doi:10.3390/ijms23031288
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhuang X, Huang Z, et al. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis. 2018;1864:238–251. doi:10.1016/j.bbadis.2017.09.029
   PubMed Web of Science ®Google Scholar
• Tang SG, Liu XY, Ye JM, et al. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways. J Endocrinol. 2018;238:47–60. doi:10.1530/joe-17-0681
   PubMed Web of Science ®Google Scholar
• Zou F, Wang L, Liu H, et al. Sophocarpine suppresses NF-κB-mediated inflammation both in vitro and in vivo and inhibits diabetic cardiomyopathy. Front Pharmacol. 2019;10:1219. doi:10.3389/fphar.2019.01219
   PubMed Web of Science ®Google Scholar
• Byrne NJ, Rajasekaran NS, Abel ED, et al. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med. 2021;169:317–342. doi:10.1016/j.freeradbiomed.2021.03.046
   PubMed Web of Science ®Google Scholar
• Yan B, Ren J, Zhang Q, et al. Antioxidative effects of natural products on diabetic cardiomyopathy. J Diabetes Res. 2017;2017:2070178. doi:10.1155/2017/2070178
   PubMed Web of Science ®Google Scholar
• Zeng W, Jin L, Zhang F, et al. Naringenin as a potential immunomodulator in therapeutics. Pharmacol Res. 2018;135:122–126. doi:10.1016/j.phrs.2018.08.002
   PubMed Web of Science ®Google Scholar
• Nguyen Ngo C, Willcox JC, Lappas M. Anti-Diabetic, anti-inflammatory, and anti-oxidant effects of naringenin in an in vitro human model and an in vivo murine model of gestational diabetes mellitus. Mol Nutr Food Res. 2019;63:1900224. doi:10.1002/mnfr.201900224
   Web of Science ®Google Scholar
• Rajappa R, Sireesh D, Salai MB, et al. Treatment with naringenin elevates the activity of transcription factor Nrf2 to protect pancreatic β-cells from streptozotocin-induced diabetes in vitro and in vivo. Front Pharmacol. 2019;9:1562. doi:10.3389/fphar.2018.01562
   PubMed Web of Science ®Google Scholar
• Wang K, Chen Z, Huang L, et al. Naringenin reduces oxidative stress and improves mitochondrial dysfunction via activation of the Nrf2/ARE signaling pathway in neurons. Int J Mol Med. 2017;40:1582–1590. doi:10.3892/ijmm.2017.3134
   PubMed Web of Science ®Google Scholar
• Yang Y, He B, Zhang X, et al. Geraniin protects against cerebral ischemia/reperfusion injury by suppressing oxidative stress and neuronal apoptosis via regulation of the Nrf2/HO-1 pathway. Oxid Med Cell Longev. 2022;18:2152746. doi:10.1155/2022/2152746
   Google Scholar
• Feng J, Luo J, Deng L, et al. Naringenin-induced HO-1 ameliorates high glucose or free fatty acids-associated apoptosis via PI3 K and JNK/Nrf2 pathways in human umbilical vein endothelial cells. Int Immunopharmacol. 2019;75:105769. doi:10.1016/j.intimp.2019.105769
   PubMed Web of Science ®Google Scholar
• Zhang B, Wan S, Liu H, et al. Naringenin alleviates renal ischemia reperfusion injury by suppressing ER stress-induced pyroptosis and apoptosis through activating Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev. 2022;2022:5992436. doi:10.1155/2022/5992436
   PubMed Web of Science ®Google Scholar
• He Y, Wang S, Sun H, et al. Naringenin ameliorates myocardial injury in STZ-induced diabetic mice by reducing oxidative stress, inflammation and apoptosis via regulating the Nrf2 and NF-κB signaling pathways. Front Cardiovasc Med. 2022;9:946766. doi:10.3389/fcvm.2022.946766
   PubMed Web of Science ®Google Scholar
• Teng J, Li Y, Yu W, et al. Naringenin, a common flavanone, inhibits the formation of AGEs in bread and attenuates AGEs-induced oxidative stress and inflammation in RAW264.7 cells. Food Chem. 2018;269:35–42. doi:10.1016/j.foodchem.2018.06.126
   PubMed Web of Science ®Google Scholar
• Sarmah S, Goswami A, Kumar Belwal V, et al. Mitigation of ribose and glyoxal induced glycation, AGEs formation and aggregation of human serum albumin by citrus fruit phytochemicals naringin and naringenin: an insight into their mechanism of action. Food Res Int. 2022;157:111358. doi:10.1016/j.foodres.2022.111358
   PubMed Web of Science ®Google Scholar
• Liu G, Xia Q, Lu Y, et al. Influence of quercetin and its methylglyoxal adducts on the formation of α-dicarbonyl compounds in a lysine/glucose model system. J Agric Food Chem. 2017;65:2233–2239. doi:10.1021/acs.jafc.6b05811
   PubMed Web of Science ®Google Scholar
• Ofosu FK, Elahi F, Daliri EB, et al. Phenolic profile, antioxidant, and antidiabetic potential exerted by millet grain varieties. Antioxidants. 2020;9:254. doi:10.3390/antiox9030254
   Web of Science ®Google Scholar
• Liu X, Wang N, Fan S, et al. The citrus flavonoid naringenin confers protection in a murine endotoxaemia model through AMPK-ATF3-dependent negative regulation of the TLR4 signalling pathway. Sci Rep. 2016;6:39735. doi:10.1038/srep39735
   PubMed Web of Science ®Google Scholar
• Yang Q, Gao L, Hu X, et al. Smad3-Targeted therapy protects against cisplatin-induced AKI by attenuating programmed cell death and inflammation via a NOX4-dependent mechanism. Kidney Dis. 2021;7:372–390. doi:10.1159/000512986
   Google Scholar
• Al Dosari DI, Ahmed MM, Al Rejaie SS, et al. Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic Rat retina. Nutrients. 2017;9:1161. doi:10.3390/nu9101161
   PubMed Web of Science ®Google Scholar
• Wojnar W, Zych M, Kaczmarczyk Sedlak I. Antioxidative effect of flavonoid naringenin in the lenses of type 1 diabetic rats. Biomed Pharmacother. 2018;108:974–984. doi:10.1016/j.biopha.2018.09.092
   PubMed Web of Science ®Google Scholar
• López-Chillón MT, Carazo-Díaz C, Prieto-Merino D, et al. Effects of long-term consumption of broccoli sprouts on inflammatory markers in overweight subjects. Clin Nutr. 2019 Apr;38(2):745–752. doi:10.1016/j.clnu.2018.03.00
   PubMed Web of Science ®Google Scholar
• Lather A, Sharma S, Khatkar A. Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: synthesis, antioxidants, antimicrobial, preservative efficacy, molecular docking and in silico ADMET analysis. BMC Chem. 2020 Jun 19;14(1):41. doi:10.1186/s13065-020-00693-3
   PubMed Web of Science ®Google Scholar
• Rebello CJ, Beyl RA, Lertora JJL, et al. Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial. Diabetes Obes Metab. 2020;22:91–98. doi:10.1111/dom.13868
   PubMed Web of Science ®Google Scholar
• Naeini F, Namkhah Z, Tutunchi H, et al. Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial. Eur J Gastroenterol Hepatol. 2022;34:345–353. doi:10.1097/meg.0000000000002323
   PubMed Web of Science ®Google Scholar
• Naeini F, Namkhah Z, Tutunchi H, et al. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. Trials. 2021;22:801. doi:10.1186/s13063-021-05784-7
   PubMed Web of Science ®Google Scholar
• Habauzit V, Verny MA, Milenkovic D, et al. Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: a randomized, controlled, crossover trial. Am J Clin Nutr. 2015;102:66–74. doi:10.3945/ajcn.114.104646
   PubMed Web of Science ®Google Scholar